A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Subtle clues—from handwriting to snoring—can reveal the earliest warnings of illness. Here's how to read your own distress signals.

Novocure today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working to extend survival ...

According to the report, death rates are increasing for certain types, including oral, pancreatic, uterine ... of the nipple ...

ATOM - led by the European Organisation for Research and Treatment of Cancer (EORTC) to evaluate KIMMTRAK as adjuvant ... targeted specifically to the pancreatic beta-cell and intended as a ...

It is in phase 2 for pancreatic, lung and breast cancer indications ... vital for Novartis if it is to weather an upcoming rash of patent expiries for drugs like CML therapy Tasigna (nilotinib ...

For a patient with advanced pancreatic cancer, immunotherapy helped significantly prolong ... Common side effects include rash, diarrhea, fatigue, and inflammation of organs like the lungs or liver.

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

Gastroenterologist Dr. Rohan Mandaliya of The Center for Comprehensive Pancreatic Care at Mercy goes over the risk factors of ...